SCHEMBL4909372

SCHEMBL4909372

Cc1ccc2c(c1)NC(C)CCN2C(=O)c1ccc(Br)c(O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.40
BRD4 O60885 2/20 0.39
HPGD P15428 4/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
TP53 P04637 2/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912334 0.87 GPBAR1 (0.42) MGLLBRD4HPGDALDH1A1SMN1; SMN2
SCHEMBL4907240 0.87 GPBAR1 (0.42) MGLLBRD4HPGDALDH1A1SMN1; SMN2
SCHEMBL4902336 0.85 ALDH1A1 (0.38) BRD4HPGDALDH1A1TSHRSMN1; SMN2
SCHEMBL4906946 0.74 GPBAR1 (0.41) BRD4ALDH1A1NPSR1GPBAR1RAB9A
SCHEMBL4904274 0.74 PDE4A (0.47) BRD4ALDH1A1KMT2ALMNA
SCHEMBL4912090 0.74 BRD4 (0.37) BRD4ALDH1A1TSHRNPSR1GPBAR1
SCHEMBL4910164 0.74 ALDH1A1 (0.37) BRD4ALDH1A1TSHRNPSR1GPBAR1
SCHEMBL4915030 0.74 PDE4A (0.47) BRD4ALDH1A1KMT2ALMNA
SCHEMBL4911740 0.74 BRD4 (0.37) BRD4HPGDALDH1A1SMN1; SMN2NPSR1
SCHEMBL4911884 0.73 SLC22A12 (0.46) BRD4ALDH1A1NPSR1GPBAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076760-A1 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION WAKAMOTO PHARMACEUTICAL CO., LTD (JP) 2008-03-27 US disclosed
EP-1820799-A1 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION Wakamoto Pharmaceutical Co., Ltd. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076760-A1 2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION GABRA5, GABRA1, GABRB1 MGLL 4809/4885BRD4 295/4885HPGD 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.